Boston Scientific Cuts 2026 Earnings Forecast After Second-Quarter Profit Beats Estimates

businesscompany-earnings 3 posts · 3 accounts

Boston Scientific posted second-quarter adjusted earnings of $0.86 a share, beating analyst estimates of $0.83, while net sales reached $5.44 billion, a 7.5% year-over-year increase.

The company cut its full-year adjusted earnings per share outlook to $3.28-$3.32, missing the consensus of $3.36, and set third-quarter guidance between $0.80 and $0.82. Management completed a $2 billion accelerated share repurchase program during the period.

From the sources (3 posts)

@alphasenseinc

$BSX Earnings: - Net sales of $5.442 billion during the second quarter of 2026, growing 7.5 percent on a reported basis and 7.0 percent on an operational and organic basis, all compared to the prior year period. - The company reported GAA

@blckchaindaily

🚨 BOSTON SCIENTIFIC $BSX Q2 ADJ EPS 86C BEATS 83C EST, NET SALES $5.44B BEATS $5.36B; SEES Q3 ADJ EPS 80C-82C BELOW 84C EST; CUTS FY ADJ EPS VIEW TO $3.28-$3.32 FROM $3.34-$3.41

@wallstengine

BOSTON SCIENTIFIC $BSX Q2’26 EARNINGS HIGHLIGHTS 🔹 Revenue: $5.44B (Est. $5.36B) 🟢; +7.5% YoY 🔹 Adj. EPS: $0.86 (Est. $0.83) 🟢; +15% YoY FY26 Guide: 🔹 Adj. EPS: $3.28-$3.32 (Est. $3.36) 🔴 🔹 Net Sales Growth: 5.5%-6.5% reporte Q3'26 Guide

Stellantis Swings to Profit but Shares Drop 5% on Earnings Miss Taiwan Prosecutors Detain Nvidia Employee in AI Chip Smuggling Probe